For the Inventor, By the Inventor

Enter inventor name

Wellesley, MA, United States of America

Kenneth W Bair

USPTO Granted Patents = 82 (Patent Applications = 13)

CIPO Patents = 5 (Patent Applications = 3)

EPO Patents = 14 (Patent Applications = 14)

Average Co-Inventor Count = 7.2

ph-index = 18

Forward Citations = 1,088(Granted Patents)

Forward Citations (Not Self Cited) = 794(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Akron, OH (US) (2000 - 2014)
Watertown, MA (US) (2015 - 2020)
Wellesley, MA (US) (2016 - 2024)

Company Filing History:

Forma Therapeutics, Inc.

Royal Appliance Mfg., Co.

10 out of 3,222

Genentech, Inc.

4. 10 out of 29

Valo Health, Inc.

Vita-mix Corporation

Valo Early Discovery, Inc.

National City Bank

9. 1 out of 240

Techtronic Floor Care Technology Limited

10. 3 out of 832,843

Other

patents

where one patent can have more than one assignee

Years Active: 2000-2025

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

NAMPT Inhibition

HDAC Inhibitors

BET Bromodomain Inhibitors

Ubiquitin-Specific Protease Inhibitors

Thienopyrazine Carboxamides

Alpha-Cinnamide Compounds

Piperidine Derivatives

FASN Inhibition

Amido Spirocyclic Derivatives

Benzopiperazine Compositions

Tetrahydroquinoline Compositions

Bicyclic Hydroxamic Acids

82 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12336981 - Compounds and compositions for the inhibition of NAMPT (2025-06-24),

2. 11919839 - Alpha-cinnamide compounds and compositions as HDAC8 inhibitors (2024-03-05),

3. 11891365 - 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors (2024-02-06),

4. 11547701 - Compounds and compositions for the inhibition of NAMPT (2023-01-10),

5. 11485745 - Amido spirocyclic amide and sulfonamide derivatives (2022-11-01),

6. 11479564 - Piperidine derivatives and compositions for the inhibition of nicotinamide phosphoribosyltransferase (NAMPT) (2022-10-25),

7. 11414392 - [6,6] fused bicyclic HDAC8 inhibitors (2022-08-16),

8. 11325917 - Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors (2022-05-10),

9. 11279687 - Compounds and compositions for the inhibition of NAMPT (2022-03-22),

10. 11279681 - 3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors (2022-03-22),

11. 11111229 - Tetrahydroquinoline compositions as BET bromodomain inhibitors (2021-09-07),

12. 11084831 - Benzopiperazine compositions as BET bromodomain inhibitors (2021-08-10),

13. 10995078 - Compounds and compositions for inhibition of FASN (2021-05-04),

14. 10988450 - 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors (2021-04-27),

15. 10988441 - Alpha-cinnamide compounds and compositions as HDAC8 inhibitors (2021-04-27),

Title: The Innovative Journey of Kenneth W Bair

Introduction: Kenneth W Bair, a distinguished inventor hailing from Wellesley, MA, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Kenneth W Bair's latest patents showcase his commitment to innovation, with a focus on advancements in renewable energy technologies and sustainable solutions for everyday challenges.

Career Highlights: Throughout his illustrious career, Kenneth W Bair has been at the forefront of technological innovation, with a keen focus on developing cutting-edge solutions that have the potential to revolutionize industries.

Collaborations: Kenneth W Bair has collaborated with leading research institutions, universities, and companies to bring his inventions to life, fostering a culture of innovation and collaboration in the process.

Conclusion: Kenneth W Bair's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and entrepreneurs, leaving an indelible mark on the world of technology.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…